DRUG · Unmapped registry intervention
MRTX849
Find medicine records ·
Find other trials using this name
Clinical trial
Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)
NCT04330664
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
TNO155
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedAdagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Advanced Cancerunresolved
Malignant Neoplastic Diseaseverified · MONDO: cancer
Interventions
Sponsors & collaborators
Mirati Therapeutics Inc.lead sponsor
Novartiscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04330664 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.